Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases Read more
Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care Read more
Boehringer Ingelheim secures novel immune checkpoint inhibitor with acquisition of Nerio Therapeutics Read more
Novartis Scemblix granted FDA Priority Review for the treatment of adults with newly diagnosed CML Read more
Bayer announces positive topline results for NUBEQA (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC) Read more
Merck Begins Commercial Production of First GMP-Compliant Manufacturing Line for Cell Culture Media in China Read more
Johnson & Johnson strengthens pipeline to lead in atopic dermatitis with acquisition of Yellow Jersey Therapeutics Read more
Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD) Read more